Berg Madeline L, Ayres Ashley M, Weber David R, McCullough Melissa, Crall Victoria D, Lewis Casey L, Valek Abby L, Vincent Lizabeth A, Penzelik Joseph, Sasinoski Crystal A, Cheng Amanda L, Bradford Claire F, Bell Elizabeth O, Edwards Kimberly M, Castronova Isabella A, Brady Mya B, Slaughter Julie, Oleksiuk Louise-Marie, Snyder Graham M
Department of Infection Prevention and Control, UPMC Presbyterian/Shadyside, Pittsburgh, Pennsylvania.
Division of Laboratory Medicine, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Antimicrob Steward Healthc Epidemiol. 2023 Apr 5;3(1):e67. doi: 10.1017/ash.2023.141. eCollection 2023.
To evaluate the impact of a diagnostic stewardship intervention on healthcare-associated infections (HAI).
Quality improvement study.
Two urban acute care hospitals.
All inpatient stool testing for required review and approval prior to specimen processing in the laboratory. An infection preventionist reviewed all orders daily through chart review and conversations with nursing; orders meeting clinical criteria for testing were approved, orders not meeting clinical criteria were discussed with the ordering provider. The proportion of completed tests meeting clinical criteria for testing and the primary outcome of HAI were compared before and after the intervention.
The frequency of completed orders not meeting criteria was lower [146 (7.5%) of 1,958] in the intervention period (January 10, 2022-October 14, 2022) than in the sampled 3-month preintervention period [26 (21.0%) of 124; P < .001]. HAI rates were 8.80 per 10,000 patient days prior to the intervention (March 1, 2021-January 9, 2022) and 7.69 per 10,000 patient days during the intervention period (incidence rate ratio, 0.87; 95% confidence interval, 0.73-1.05; P = .13).
A stringent order-approval process reduced clinically nonindicated testing for but did not significantly decrease HAIs.
评估诊断管理干预对医疗相关感染(HAI)的影响。
质量改进研究。
两家城市急症医院。
实验室在处理标本前,所有住院患者的粪便检测都需经过审核和批准。一名感染预防专员每天通过病历审查和与护理人员交谈来审查所有医嘱;符合检测临床标准的医嘱予以批准,不符合临床标准的医嘱与开医嘱的医生进行讨论。比较干预前后符合检测临床标准的已完成检测比例以及HAI的主要结局。
在干预期间(2022年1月10日至2022年10月14日),不符合标准的已完成医嘱频率[1958例中的146例(7.5%)]低于干预前3个月的抽样期[124例中的26例(21.0%);P <.001]。干预前(2021年3月1日至2022年1月9日)HAI发生率为每10000患者日8.80例,干预期间为每10000患者日7.69例(发病率比,0.87;95%置信区间,0.73 - 1.05;P = 0.13)。
严格的医嘱审批流程减少了临床上不必要的检测,但并未显著降低HAI。